BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 33340622)

  • 21. The interaction between nanoparticles-protein corona complex and cells and its toxic effect on cells.
    Liu N; Tang M; Ding J
    Chemosphere; 2020 Apr; 245():125624. PubMed ID: 31864050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein corona: a new approach for nanomedicine design.
    Nguyen VH; Lee BJ
    Int J Nanomedicine; 2017; 12():3137-3151. PubMed ID: 28458536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The protein corona on nanoparticles as viewed from a nanoparticle-sizing perspective.
    Wang H; Lin Y; Nienhaus K; Nienhaus GU
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1500. PubMed ID: 29071798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brownian motion-based nanoparticle sizing-A powerful approach for in situ analysis of nanoparticle-protein interactions.
    Nienhaus K; Nienhaus GU
    Biointerphases; 2020 Dec; 15(6):061201. PubMed ID: 33356335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the Lipid and Protein Corona Formation on Different Sized Polymeric Nanoparticles.
    Lima T; Bernfur K; Vilanova M; Cedervall T
    Sci Rep; 2020 Jan; 10(1):1129. PubMed ID: 31980686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering the protein corona: Strategies, effects, and future directions in nanoparticle therapeutics.
    Zhao T; Ren M; Shi J; Wang H; Bai J; Du W; Xiang B
    Biomed Pharmacother; 2024 Jun; 175():116627. PubMed ID: 38653112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles Penetrate into the Multicellular Spheroid-on-Chip: Effect of Surface Charge, Protein Corona, and Exterior Flow.
    Huang K; Boerhan R; Liu C; Jiang G
    Mol Pharm; 2017 Dec; 14(12):4618-4627. PubMed ID: 29096441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of nanoparticle-protein interactions by electrophoresis techniques.
    Zarei M; Aalaie J
    Anal Bioanal Chem; 2019 Jan; 411(1):79-96. PubMed ID: 30317444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of protein corona magnetite nanoparticles derived from bread in vitro digestion on Caco-2 cells morphology and uptake.
    Di Silvio D; Rigby N; Bajka B; Mackie A; Baldelli Bombelli F
    Int J Biochem Cell Biol; 2016 Jun; 75():212-22. PubMed ID: 26520468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein corona - from molecular adsorption to physiological complexity.
    Treuel L; Docter D; Maskos M; Stauber RH
    Beilstein J Nanotechnol; 2015; 6():857-73. PubMed ID: 25977856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
    Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Corona Formation on Colloidal Polymeric Nanoparticles and Polymeric Nanogels: Impact on Cellular Uptake, Toxicity, Immunogenicity, and Drug Release Properties.
    Obst K; Yealland G; Balzus B; Miceli E; Dimde M; Weise C; Eravci M; Bodmeier R; Haag R; Calderón M; Charbaji N; Hedtrich S
    Biomacromolecules; 2017 Jun; 18(6):1762-1771. PubMed ID: 28511014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum.
    Mirshafiee V; Kim R; Mahmoudi M; Kraft ML
    Int J Biochem Cell Biol; 2016 Jun; 75():188-95. PubMed ID: 26643610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Surface-Engineered ZnO Nanoparticles on Protein Corona Configuration and Their Interactions With Biological System.
    Srivastav AK; Dhiman N; Khan H; Srivastav AK; Yadav SK; Prakash J; Arjaria N; Singh D; Yadav S; Patnaik S; Kumar M
    J Pharm Sci; 2019 May; 108(5):1872-1889. PubMed ID: 30615879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro in-vivo correlation (IVIVC) in nanomedicine: Is protein corona the missing link?
    Jain P; Pawar RS; Pandey RS; Madan J; Pawar S; Lakshmi PK; Sudheesh MS
    Biotechnol Adv; 2017 Nov; 35(7):889-904. PubMed ID: 28844973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
    Randhawa S; Abidi SMS; Dar AI; Acharya A
    Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Corona Formation Impacts Nanomaterials as Drug Carriers.
    Gupta MN; Roy I
    Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles.
    Chen D; Ganesh S; Wang W; Amiji M
    AAPS J; 2020 Jun; 22(4):83. PubMed ID: 32495039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints.
    Afantitis A; Melagraki G; Tsoumanis A; Valsami-Jones E; Lynch I
    Nanotoxicology; 2018 Dec; 12(10):1148-1165. PubMed ID: 30182778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.